Skip to content

Analysis of the effect of different laxatives on the residual activity and efficacy of radioactive residual radioactivity in DTC patients after 131I treatment.

Analysis of the effect of different laxatives on the residual activity and efficacy of radioactive residual radioactivity in DTC patients after 131I treatment.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600130672
Enrollment
Unknown
Registered
2026-08-23
Start date
2025-06-01
Completion date
Unknown
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

Blank group:None
senna group:None
rhubarb group:None

Sponsors

The first affiliated hostipal of nanchang university
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Total thyroidectomy or near-total thyroidectomy was performed, and the postoperative pathological diagnosis was DTC. 2.According to the "Guidelines for the Treatment of Differentiated Thyroid Cancer with 131I (2021 Edition)", there are indications for 131I treatment after thyroid cancer. 3.TSH > 30 mIU/ml in the stimulated state before iodine treatment. 4.Complete surgical records, pathology reports, relevant imaging and laboratory examination data; 5.Consciousness is clear and able to communicate verbally.

Exclusion criteria

Exclusion criteria: 1.Patients with postoperative wounds that have not healed. 2.Pregnant and lactating women, planning to become pregnant in the short term (6 months). 3.There is severe dysfunction of the heart, liver, kidney and other organs. 4.Presence of significant gastrointestinal discomfort or major gastrointestinal disease. 5.Those who have obvious allergic reactions to lactulose, rhubarb and senna and cannot tolerate it.

Design outcomes

Primary

MeasureTime frame
Iodine uptake rate;Thyroglobulin and related antibodies;Imaging related tests;Whole body residual activity;

Secondary

MeasureTime frame
Thyroid function;Liver function;Visual scoring of gastrointestinal radionuclide retention on ¹³¹I whole-body scan;Radioactive counts of residual radionuclide in the gastrointestinal tract/residual/background on ¹³¹I whole-body scan;Kidney function;TSH (thyroid-stimulating hormone);sTgAb (stimulated thyroglobulin antibody);sTg (stimulated thyroglobulin);

Countries

China

Contacts

Public ContactZhang Qing

The first affiliated hostipal of nanchang university

10187476@qq.com+86 791 8890889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026